Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nasser Al-Sanea

Showing results (11-20 of 28) with videos related to

Pageof 3
Sort By:
The American Journal of Gastroenterology|June 4, 2009
High prevalence of fatty acid synthase expression in colorectal cancers in Middle Eastern patients and its potential role as a therapeutic targetShahab Uddin, Azhar R Hussain, Maqbool Ahmed, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|April 7, 2012
Colorectal cancer risk is not associated with increased levels of homozygosity in Saudi ArabiaAbdul K Siraj, Hanif G Khalak, Mehar Sultana, et al.
Carcinogenesis|June 13, 2009
Leptin receptor expression in Middle Eastern colorectal cancer and its potential clinical implicationShahab Uddin, Prashant P Bavi, Azhar R Hussain, et al.
Gut|February 11, 2017
<i>MED12</i> is recurrently mutated in Middle Eastern colorectal cancerAbdul K Siraj, Tariq Masoodi, Rong Bu, et al.
Cancer Research|May 3, 2008
Bortezomib (Velcade) induces p27Kip1 expression through S-phase kinase protein 2 degradation in colorectal cancerShahab Uddin, Maqbool Ahmed, Prashant Bavi, et al.
Clinical and Experimental Gastroenterology|February 19, 2021
Epidemiology of Pancreatic Cancer in Saudi Arabia: A Retrospective Analysis of Pancreatic Cancer Diagnosed in Saudi Arabia Between 2004 and 2015Ibrahim G Alghamdi, Majid Almadi, Fahad Alsohaibani, et al.
The Journal of Pathology|October 14, 2009
Prognostic significance of alterations in KRAS isoforms KRAS-4A/4B and KRAS mutations in colorectal carcinomaJehad Abubaker, Prashant Bavi, Wael Al-Haqawi, et al.
The American Journal of Pathology|February 2, 2011
Genome-wide expression analysis of Middle Eastern colorectal cancer reveals FOXM1 as a novel target for cancer therapyShahab Uddin, Maqbool Ahmed, Azhar Hussain, et al.
Molecular Cancer|July 10, 2014
A very low incidence of BRAF mutations in Middle Eastern colorectal carcinomaAbdul K Siraj, Rong Bu, Sarita Prabhakaran, et al.
The Journal of Pathology|August 22, 2009
Frequent PIK3CA gene amplification and its clinical significance in colorectal cancerZeenath Jehan, Prashant Bavi, Mehar Sultana, et al.
Pageof 3

Showing results (11-20 of 28) with videos related to

Sort By:
Pageof 3
The American Journal of Gastroenterology|June 4, 2009
High prevalence of fatty acid synthase expression in colorectal cancers in Middle Eastern patients and its potential role as a therapeutic targetShahab Uddin, Azhar R Hussain, Maqbool Ahmed, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|April 7, 2012
Colorectal cancer risk is not associated with increased levels of homozygosity in Saudi ArabiaAbdul K Siraj, Hanif G Khalak, Mehar Sultana, et al.
Carcinogenesis|June 13, 2009
Leptin receptor expression in Middle Eastern colorectal cancer and its potential clinical implicationShahab Uddin, Prashant P Bavi, Azhar R Hussain, et al.
Gut|February 11, 2017
<i>MED12</i> is recurrently mutated in Middle Eastern colorectal cancerAbdul K Siraj, Tariq Masoodi, Rong Bu, et al.
Cancer Research|May 3, 2008
Bortezomib (Velcade) induces p27Kip1 expression through S-phase kinase protein 2 degradation in colorectal cancerShahab Uddin, Maqbool Ahmed, Prashant Bavi, et al.
Clinical and Experimental Gastroenterology|February 19, 2021
Epidemiology of Pancreatic Cancer in Saudi Arabia: A Retrospective Analysis of Pancreatic Cancer Diagnosed in Saudi Arabia Between 2004 and 2015Ibrahim G Alghamdi, Majid Almadi, Fahad Alsohaibani, et al.
The Journal of Pathology|October 14, 2009
Prognostic significance of alterations in KRAS isoforms KRAS-4A/4B and KRAS mutations in colorectal carcinomaJehad Abubaker, Prashant Bavi, Wael Al-Haqawi, et al.
The American Journal of Pathology|February 2, 2011
Genome-wide expression analysis of Middle Eastern colorectal cancer reveals FOXM1 as a novel target for cancer therapyShahab Uddin, Maqbool Ahmed, Azhar Hussain, et al.
Molecular Cancer|July 10, 2014
A very low incidence of BRAF mutations in Middle Eastern colorectal carcinomaAbdul K Siraj, Rong Bu, Sarita Prabhakaran, et al.
The Journal of Pathology|August 22, 2009
Frequent PIK3CA gene amplification and its clinical significance in colorectal cancerZeenath Jehan, Prashant Bavi, Mehar Sultana, et al.
Pageof 3